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Introduction: l1~-Hydroxysteroid dehydrogenase activity is 
responsible for the interconversion of cortisol and cortisone. 
Its presence in granulosa-lutein (GL) cells is associated with 
a poor outcome in IVF (Michael et at., 1993). Recently we 
have developed a simple rapid «8 h) method of assessing 
the reductase activity of the type 1 isoform in GL cells (Knaggs 
et a!., 1996). In this pilot study we assayed the enzyme's 
activity in all the individual follicles aspirated from patients 
undergoing IVF. 
Materials and methods: Cells from individual follicular 
aspirates (n = 107 from 20 patients) were plated (12 500 
cells/well) into 96-well plates and challenged with cortisone 
(6X 1O--{j M) for 2 h at 37°C within 1 h of aspiration. Cortisol 
secretion was measured by a radioimmunoassay (intra- and 
interassay coefficients of variation <10 and <14% respect-
ively). The DNA content of each well was assessed by a 
Hoescht fluorescent dye binding assay. 
Results: The intra-assay coefficient of variation for the reduc-
tase activity, based on 107 cell preparations each assayed in 
quadruplicate, was 13%. It varied considerably between foll-
icles both within and between patients (range 0.001-0.560 
nmol cortisolillg DNA). Enzymatic activity was [median 
(range)] 0.04 (0.0012-0.14) nmol cortisolillg DNA in the 
follicles (n = 22) from the four patients who became pregnant 
compared with 0.05 (0.002-0.56; n = 85 follicles from 16 
patients) nmol cortisolillg DNA in those who did not conceive. 
Follicles which gave rise to oocytes leading to a pregnancy 
cycle had levels of 0.05 (0.001-0.08; n = 10) as opposed to 
0.04 (0.002-0.33; n = 31) nmol cortisolillg DNA for cells 
from follicles that produced a transferred embryo which failed 
to result in a pregnancy. However, there were no differences 
between the groups because of the small number of patients 
who were infertile for various reasons. 
Conclusion: This method is suitable for assessing enzymatic 
activity in GL cells isolated from follicles aspirated from 
patients undergoing IVF. This work on a series of 20 patients 
forms part of a prospective study to assess whether 11~­
reductase activity in GL cells from individual follicles may be 
used as a predictor of IVF success. At present the low patient 
numbers preclude a meaningful correlation between 11~­
reductase activity and pregnancy rate. 
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Introduction: Non-placental pregnancy-specific ~l-glycopro­
tein (SP1) is a monomeric, heavily glycosylated (29%) protein 
of syncytiotrophoblastic origin. Its serum concentration rises 
222 
steeply in early pregnancy, allowing a dating superior to that 
of ultrasound before 6 weeks of gestation. It appears 1-3 days 
after HCG, a small but significant delay which has prevented 
its use in IVF programmes. With a sensitive assay, small SP1 
signals were recorded at around the time of oocyte retrieval 
and embryo transfer, i.e. at a time incompatible with a 
trophoblastic source. Previous observations have shown that 
this 'abnormal SP1 pattern' occurred in all cycles of a defined 
group of non-pregnant patients. The aim of this study was to 
retrospectively analyse SP1 versus outcome in a larger group 
of patients. 
Materials and methods: The study included 182 consecutive 
conventional IVF and embryo transfer treatment cycles. Stand-
ardized serum collection was performed on day 2, before the 
initiation of ovarian stimulation on oocyte retrieval day -1 
(OPU-1) and on embryo transfer day + 14 (ET+ 14). Of these 
cycles, 45 gave rise to either a spontaneous early abortion 
(n = 8) or an ongoing pregnancy (n = 37). SP1 was determined 
using an ultrasensitive (0.02 ng/ml) microplate ELISA method 
developed in our laboratory. 
Results: A longitudinal (paired) analysis showed no difference 
in serum SPI between days 2 and OPU-1 in pregnant and 
non-pregnant groups. On the other hand, the concentrations at 
ET + 14 were significantly higher (200%) than at OPU-1; again 
this increase did not depend on outcome and was observed 
consistently, even in the implantation failure group. A cross-
sectional analysis showed no significant differences between 
outcome groups at any of the three selected time points. 
Nevertheless, a frequency analysis indicated that at days 2 and 
OPU-1 the cycles of subsequently pregnant women were 
homogenously distributed, while those not leading to pregnancy 
were scattered over a wider range. At ET+ 14 there was less 
homogeneity in both groups. 
Conclusion: The SP1 frequency distribution patterns observed 
on days 2 and OPU-1 suggest the presence of a subpopulation 
of women with a 'high' serum SP1 concentration and a reduced 
pregnancy prognosis because none of these women became 
pregnant. An endometrial factor or other endocrine effect may 
play a role in influencing ectopic SP1 production as well as 
embryo implantation. This should be investigated further to 
identify low-chance patients. At ET+ 14 such an analysis 
carries no advantage because the pregnancy subgroup also 
contains women with sera with high SP1 concentrations, 
probably because of early or multiple implantations, and with 
low SP1, probably because of poor embryo quality or delayed 
implantation. From a clinical point of view, HCG remains 
superior to SP1 as an indicator of pregnancy after embryo 
transfer, even when HCG is used as luteal phase support. 
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Introduction: Subclinical pregnancy loss has been documented 
in normal and infertile women. We have previously reported 
